Powered Systems, Instruments, and Imaging device(s), Advanced Energy device(s), Robotics and Navigation, Rods and Screws, Interbodies and Biologics, Spinal Tethers, and Other Spinal Hardware device(s)

Follow-up assessments will be required (therefore interventional) from pre-operative baseline to 24 months post index surgery

Defined by amount of: 1) blood loss (mL) during surgery and/or 2) total operation time and/or 3) length of stay in the hospital (measured from surgery completion to discharge), and/or 4) investigator opinion on whether the device(s) directly assisted in the completion of surgery

Fusion success at 12-months is determined through evaluation of radiographic evidence (X-ray and/or CT scan) by the investigator by: (1) Confirming the presence of bone bridging, and (2) if using the Brantigan & Steffee's Classification scale: a score D and/or E are determined.

Surgical performance, as defined as the rate at which the device directly assisted in the completion of surgery in the investigator's opinion.

If O-Arm used: whether O-Arm was utilized for validation of implant placement during the surgery.

Robotics: Planned number of screws prior to index surgery compared to number of screws device assisted with placement during surgery. Navigation: Whether or not device was utilized for validation of screw placement during surgery.

Resolution of pain at 12-months when compared to baseline Pain reported by the subject using the Neck Disability Index (NDI) questionnaire

The secondary endpoint is defined as the rate of occurrence for device-related adverse events